Replies to post #24377 on Relief Therapeutics Holding AG (RLFTF)

[nelskof]

I went back into search mode today on other covid therapeutics like BP Regeneron & Eli Lilly and all other front-runners. My big takeaway was that they're all progressing slower than their initial timeline estimates. (vaccines too)

The data of the early trial results are luke worm and don't compete directly with Relief, in either severe patients or outpatient inhaler. Where there is crossover they can both be applied.

Taking the 28 days at face value there is no company or drug "ahead" of Aviptadil.

Obviously, no one else has an EUA app submitted. Only a couple of Big Pharmas have connections and leadership like NeuroRx but they don't have Samivir or Samiair! The science is going to ultimately prevail.

Timing may have changed on a couple of aspects but the outcome still looks the same.